BREAKING: After Spritam, the second 3D printed drug gets recognized by the FDA . Chinese pharmaceutical company Triastek, Inc. has received Investigational New Drug (IND) approval from the FDA for its first 3D printed drug product, T19, which is designed to treat rheumatoid arthritis. Amazing news for the industry as it opens up a range of opportunities to bring the supply chain to the next text level. #triastek #fda #3dprinting #3dprinter #3dprinted #themedicalfuturist #digitalhealth #future #healthcare #technology …see more